1
|
Sachdeva H, Khaturia S, Saquib M, Khatik N, Khandelwal AR, Meena R, Sharma K. Oxygen- and Sulphur-Containing Heterocyclic Compounds as Potential Anticancer Agents. Appl Biochem Biotechnol 2022; 194:6438-6467. [PMID: 35900713 DOI: 10.1007/s12010-022-04099-w] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/15/2022] [Indexed: 11/28/2022]
Abstract
Oxygen- and sulphur-based heterocycles form the core structure of many biologically active molecules as well as U.S. FDA-approved drugs. Moreover, they possess broad range of biological activities, viz. anticancer, antiinflammatory, antioxidant, antitumour, antibacterial, antiviral, antidiabetic, anticonvulsant, anti-tubercular, analgesic, anti-leishmanial, antimalarial, antifungal, and anti-histaminic, Hence, O- and S-based heterocycles are gaining more attention in recent years on the road to the discovery of innovative anticancer drugs after the extensive investigation of nitrogen-based heterocycles as anticancer agents. Several attempts have been made to synthesize fused oxygen- and sulphur-based heterocyclic derivatives as joining one heterocyclic moiety with another may lead to improvement in the biological profile of a molecule. Humans have been cursed with cancer since long time. Despite the development of several heterocyclic anticancer medications such as 5-fluorouracil, doxorubicin, methotrexate, and daunorubicin, cure of cancer is difficult. Hence, researchers are trying to synthesize new fused/spiro heterocyclic molecules to discover novel anticancer drugs which may show promising anticancer effects with fewer side effects. Furthermore, fused heterocycles behave as DNA intercalating agents which have the ability to interact with DNA, leading to cell death thereby exerting anticancer effect. This review article highlights the synthesis and anticancer potentiality of oxygen- and sulphur-containing heterocyclic compounds covering the period from 2011 to 2021.
Collapse
Affiliation(s)
- Harshita Sachdeva
- Department of Chemistry, University of Rajasthan, 302004, Jaipur, Rajasthan, India.
| | - Sarita Khaturia
- Department of Chemistry, School of Liberal Arts and Sciences, Mody University of Science and Technology, Lakshmangarh (Sikar), Rajasthan, India
| | - Mohammad Saquib
- Department of Chemistry, Manipal Institute of Technology, Manipal Academy of Higher Education, Manipal, Karnataka, India
| | - Narsingh Khatik
- Department of Chemistry, University of Rajasthan, 302004, Jaipur, Rajasthan, India
| | | | - Ravina Meena
- Department of Chemistry, University of Rajasthan, 302004, Jaipur, Rajasthan, India
| | - Khushboo Sharma
- Department of Chemistry, University of Rajasthan, 302004, Jaipur, Rajasthan, India
| |
Collapse
|
2
|
Bhurta D, Bharate SB. Styryl Group, a Friend or Foe in Medicinal Chemistry. ChemMedChem 2022; 17:e202100706. [PMID: 35166041 DOI: 10.1002/cmdc.202100706] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2021] [Revised: 02/12/2022] [Indexed: 11/10/2022]
Abstract
The styryl (Ph-CH=CH-R) group is widely represented in medicinally important compounds, including drugs, clinical candidates, and molecular probes as it positively impacts the lipophilicity, oral absorption, and biological activity. The analysis of matched molecular pairs (styryl vs. phenethyl, phenyl, methyl, H) for the biological activity indicates the superiority aspect of styryl compounds. However, the Michael acceptor site in the styryl group makes it amenable to the nucleophilic attack by biological nucleophiles and transformation to the toxic metabolites. One of the downsides of styryl compounds is isomerization that impacts the molecular conformation and directly affects biological activity. The impact of cis-trans isomerism and isosteric replacements on biological activity is exemplified. We also discuss the styryl group-bearing drugs, clinical candidates, and fluorescent probes. Overall, the present review reveals the utility of the styryl group in medicinal chemistry and drug discovery.
Collapse
Affiliation(s)
- Deendyal Bhurta
- Council of Scientific & Industrial Research Indian Institute of Integrative Medicine, Natural Products and medicinal chemistry, 180001, Jammu, INDIA
| | - Sandip Bibishan Bharate
- Indian Institute of Integrative Medicine CSIR, Natural Products & Medicinal Chemistry, Canal Road, 180001, Jammu, INDIA
| |
Collapse
|
3
|
Lasso JD, Castillo-Pazos DJ, Li CJ. Green chemistry meets medicinal chemistry: a perspective on modern metal-free late-stage functionalization reactions. Chem Soc Rev 2021; 50:10955-10982. [PMID: 34382989 DOI: 10.1039/d1cs00380a] [Citation(s) in RCA: 52] [Impact Index Per Article: 17.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
The progress of drug discovery and development is paced by milestones reached in organic synthesis. In the last decade, the advent of late-stage functionalization (LSF) reactions has represented a valuable breakthrough. Recent literature has defined these reactions as the chemoselective modification of complex molecules by means of C-H functionalization or the manipulation of endogenous functional groups. Traditionally, these diversifications have been accomplished by organometallic means. However, the presence of metals carries disadvantages related to their cost, environmental hazard and health risks. Fundamentally, green chemistry directives can help minimize such hazards through the development of metal-free LSF methodologies. In this review, we expand the current discussion on metal-free LSF reactions by providing an overview of C(sp2)-H, and C(sp3)-H functionalizations, as well as the utilization of heteroatom-containing functional groups as chemical handles. Selected topics such as metal-free cross-dehydrogenative coupling (CDC) reactions, organocatalysis, electrochemistry and photochemistry are also discussed. By writing the first review on metal-free LSF methodologies, we aim to highlight current advances in the field with examples that reveal specific challenges and solutions, as well as future research opportunities.
Collapse
Affiliation(s)
- Juan D Lasso
- Department of Chemistry, FRQNT Centre for Green Chemistry and Catalysis, McGill University, 801 Sherbrooke St. W., Montreal, Quebec H3A 0B8, Canada.
| | - Durbis J Castillo-Pazos
- Department of Chemistry, FRQNT Centre for Green Chemistry and Catalysis, McGill University, 801 Sherbrooke St. W., Montreal, Quebec H3A 0B8, Canada.
| | - Chao-Jun Li
- Department of Chemistry, FRQNT Centre for Green Chemistry and Catalysis, McGill University, 801 Sherbrooke St. W., Montreal, Quebec H3A 0B8, Canada.
| |
Collapse
|
4
|
|
5
|
Chiacchio MA, Lanza G, Chiacchio U, Giofrè SV, Romeo R, Iannazzo D, Legnani L. Oxazole-Based Compounds As Anticancer Agents. Curr Med Chem 2020; 26:7337-7371. [PMID: 30501590 DOI: 10.2174/0929867326666181203130402] [Citation(s) in RCA: 25] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2018] [Revised: 10/22/2018] [Accepted: 11/15/2018] [Indexed: 11/22/2022]
Abstract
Heterocyclic compounds represent a significant target for anti-cancer research and drug discovery, due to their structural and chemical diversity. Oxazoles, with oxygen and nitrogen atoms present in the core structure, enable various types of interactions with different enzymes and receptors, favoring the discovery of new drugs. Aim of this review is to describe the most recent reports on the use of oxazole-based compounds in anticancer research, with reference to the newly discovered iso/oxazole-based drugs, to their synthesis and to the evaluation of the most biologically active derivatives. The corresponding dehydrogenated derivatives, i.e. iso/oxazolines and iso/oxazolidines, are also reported.
Collapse
Affiliation(s)
- Maria A Chiacchio
- Dipartimento di Scienze del Farmaco, University of Catania, V.le Doria 6, 95125 Catania, Italy
| | - Giuseppe Lanza
- Dipartimento di Scienze del Farmaco, University of Catania, V.le Doria 6, 95125 Catania, Italy
| | - Ugo Chiacchio
- Dipartimento di Scienze del Farmaco, University of Catania, V.le Doria 6, 95125 Catania, Italy
| | - Salvatore V Giofrè
- Dipartimento di Scienze Chimiche, Biologiche, Farmaceutiche e Ambientali, University of Messina, Via S.S. Annunziata, 98168 Messina, Italy
| | - Roberto Romeo
- Dipartimento di Scienze Chimiche, Biologiche, Farmaceutiche e Ambientali, University of Messina, Via S.S. Annunziata, 98168 Messina, Italy
| | - Daniela Iannazzo
- Dipartimento di Ingegneria, University of Messina, Contrada Di Dio, 98166 Messina, Italy
| | - Laura Legnani
- Dipartimento di Scienze del Farmaco, University of Catania, V.le Doria 6, 95125 Catania, Italy.,Dipartimento di Chimica, University of Pavia, Via Taramelli 12, 27100 Pavia, Italy
| |
Collapse
|
6
|
de Sena M. Pinheiro P, Rodrigues DA, do Couto Maia R, Thota S, Fraga CA. The Use of Conformational Restriction in Medicinal Chemistry. Curr Top Med Chem 2019; 19:1712-1733. [DOI: 10.2174/1568026619666190712205025] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2019] [Revised: 05/01/2019] [Accepted: 05/05/2019] [Indexed: 12/13/2022]
Abstract
During the early preclinical phase, from hit identification and optimization to a lead compound,
several medicinal chemistry strategies can be used to improve potency and/or selectivity. The
conformational restriction is one of these approaches. It consists of introducing some specific structural
constraints in a lead candidate to reduce the overall number of possible conformations in order to favor
the adoption of a bioactive conformation and, as a consequence, molecular recognition by the target receptor.
In this work, we focused on the application of the conformational restriction strategy in the last
five years for the optimization of hits and/or leads of several important classes of therapeutic targets in
the drug discovery field. Thus, we recognize the importance of several kinase inhibitors to the current
landscape of drug development for cancer therapy and the use of G-protein Coupled Receptor (GPCR)
modulators. Several other targets are also highlighted, such as the class of epigenetic drugs. Therefore,
the possibility of exploiting conformational restriction as a tool to increase the potency and selectivity
and promote changes in the intrinsic activity of some ligands intended to act on many different targets
makes this strategy of structural modification valuable for the discovery of novel drug candidates.
Collapse
Affiliation(s)
- Pedro de Sena M. Pinheiro
- Laboratorio de Avaliacao e Síntese de Substancias Bioativas (LASSBio), Instituto de Ciencias Biomedicas, Universidade Federal do Rio de Janeiro, PO Box 68023, 21941-902, Rio de Janeiro, RJ, Brazil
| | - Daniel A. Rodrigues
- Laboratorio de Avaliacao e Síntese de Substancias Bioativas (LASSBio), Instituto de Ciencias Biomedicas, Universidade Federal do Rio de Janeiro, PO Box 68023, 21941-902, Rio de Janeiro, RJ, Brazil
| | - Rodolfo do Couto Maia
- Laboratorio de Avaliacao e Síntese de Substancias Bioativas (LASSBio), Instituto de Ciencias Biomedicas, Universidade Federal do Rio de Janeiro, PO Box 68023, 21941-902, Rio de Janeiro, RJ, Brazil
| | - Sreekanth Thota
- Laboratorio de Avaliacao e Síntese de Substancias Bioativas (LASSBio), Instituto de Ciencias Biomedicas, Universidade Federal do Rio de Janeiro, PO Box 68023, 21941-902, Rio de Janeiro, RJ, Brazil
| | - Carlos A.M. Fraga
- Laboratorio de Avaliacao e Síntese de Substancias Bioativas (LASSBio), Instituto de Ciencias Biomedicas, Universidade Federal do Rio de Janeiro, PO Box 68023, 21941-902, Rio de Janeiro, RJ, Brazil
| |
Collapse
|
7
|
Chu X, Ge D, Wang M, Rao W, Loh T, Shen Z. Chemo‐ and Regioselective Ring Construction Driven by Visible‐Light Photoredox Catalysis: an Access to Fluoroalkylated Oxazolidines Featuring an All‐Substituted Carbon Stereocenter. Adv Synth Catal 2019. [DOI: 10.1002/adsc.201900585] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Affiliation(s)
- Xue‐Qiang Chu
- Institute of Advanced Synthesis, School of Chemistry and Molecular Engineering, Jiangsu National Synergetic Innovation Center for Advanced Materials Nanjing Tech University Nanjing 211816 People's Republic of China
| | - Danhua Ge
- Institute of Advanced Synthesis, School of Chemistry and Molecular Engineering, Jiangsu National Synergetic Innovation Center for Advanced Materials Nanjing Tech University Nanjing 211816 People's Republic of China
| | - Mao‐Lin Wang
- Institute of Advanced Synthesis, School of Chemistry and Molecular Engineering, Jiangsu National Synergetic Innovation Center for Advanced Materials Nanjing Tech University Nanjing 211816 People's Republic of China
| | - Weidong Rao
- Jiangsu Key Laboratory of Biomass-based Green Fuels and Chemicals, College of Chemical Engineering Nanjing Forestry University Nanjing 210037 People's Republic of China
| | - Teck‐Peng Loh
- Institute of Advanced Synthesis, School of Chemistry and Molecular Engineering, Jiangsu National Synergetic Innovation Center for Advanced Materials Nanjing Tech University Nanjing 211816 People's Republic of China
- Division of Chemistry and Biological Chemistry, School of Physical and Mathematical Sciences Nanyang Technological University Singapore 637371 Singapore
| | - Zhi‐Liang Shen
- Institute of Advanced Synthesis, School of Chemistry and Molecular Engineering, Jiangsu National Synergetic Innovation Center for Advanced Materials Nanjing Tech University Nanjing 211816 People's Republic of China
| |
Collapse
|
8
|
Satheesh V, Vivek Kumar S, Punniyamurthy T. Expedient stereospecific Co-catalyzed tandem C–N and C–O bond formation of N-methylanilines with styrene oxides. Chem Commun (Camb) 2018; 54:11813-11816. [DOI: 10.1039/c8cc06223d] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
The Co(ii)-catalyzed stereospecific sequential C–N and C–O bond formation of styrene oxides with N-methylanilines has been developed. Optically active epoxides can be coupled with high enantiomeric purity.
Collapse
Affiliation(s)
- Vanaparthi Satheesh
- Department of Chemistry
- Indian Institute of Technology Guwahati
- Guwahati 781039
- India
| | | | | |
Collapse
|
9
|
Andrade SF, Oliveira BG, Pereira LC, Ramos JP, Joaquim AR, Steppe M, Souza-Fagundes EM, Alves RJ. Design, synthesis and structure-activity relationship studies of a novel focused library of 2,3,4-substituted oxazolidines with antiproliferative activity against cancer cell lines. Eur J Med Chem 2017. [DOI: 10.1016/j.ejmech.2017.06.022] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
|
10
|
Ahdenov R, Mohammadi AA, Taheri S, Ghaderi P, Saadat M. An Efficient Synthesis for Some New Heterocyclic Compound-fused Oxindole Derivatives. J Heterocycl Chem 2015. [DOI: 10.1002/jhet.2560] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Affiliation(s)
- R. Ahdenov
- Chemistry and Chemical Engineering Research Center of Iran (CCERCI); PO Box 14335-186 Tehran Iran
| | - A. A. Mohammadi
- Chemistry and Chemical Engineering Research Center of Iran (CCERCI); PO Box 14335-186 Tehran Iran
| | - S. Taheri
- Chemistry and Chemical Engineering Research Center of Iran (CCERCI); PO Box 14335-186 Tehran Iran
| | - P. Ghaderi
- Chemistry and Chemical Engineering Research Center of Iran (CCERCI); PO Box 14335-186 Tehran Iran
| | - M. Saadat
- Chemistry and Chemical Engineering Research Center of Iran (CCERCI); PO Box 14335-186 Tehran Iran
| |
Collapse
|
11
|
Feng H, Zhao P, Sun Z. CuI/CuBr2-catalyzed decarboxylative/A3 reaction of propiolic acids for the facile synthesis of 1,4-diheterocycle-2-butynes. Tetrahedron Lett 2015. [DOI: 10.1016/j.tetlet.2015.08.075] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
|
12
|
Heterocyclic Anticancer Compounds: Recent Advances and the Paradigm Shift towards the Use of Nanomedicine's Tool Box. Molecules 2015; 20:16852-91. [PMID: 26389876 PMCID: PMC6331900 DOI: 10.3390/molecules200916852] [Citation(s) in RCA: 355] [Impact Index Per Article: 39.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2015] [Revised: 09/08/2015] [Accepted: 09/09/2015] [Indexed: 02/07/2023] Open
Abstract
The majority of heterocycle compounds and typically common heterocycle fragments present in most pharmaceuticals currently marketed, alongside with their intrinsic versatility and unique physicochemical properties, have poised them as true cornerstones of medicinal chemistry. Apart from the already marketed drugs, there are many other being investigated for their promising activity against several malignancies. In particular, anticancer research has been capitalizing on the intrinsic versatility and dynamic core scaffold of these compounds. Nevertheless, as for any other promising anticancer drugs, heterocyclic compounds do not come without shortcomings. In this review, we provide for a concise overview of heterocyclic active compounds and families and their main applications in medicine. We shall focus on those suitable for cancer therapy while simultaneously addressing main biochemical modes of action, biological targets, structure-activity relationships as well as intrinsic limitation issues in the use of these compounds. Finally, considering the advent of nanotechnology for effective selective targeting of drugs, we shall discuss fundamental aspects and considerations on nanovectorization of such compounds that may improve pharmacokinetic/pharmacodynamic properties of heterocycles.
Collapse
|
13
|
Feng H, Jia H, Sun Z. A Metal-Free Approach Toward SaturatedN-Propargyl Heterocycles via an Annulation/Decarboxylative Coupling Sequence. Adv Synth Catal 2015. [DOI: 10.1002/adsc.201500044] [Citation(s) in RCA: 37] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
|